Top Markets
Coin of the day
GridAI Technologies Corp. GridAI Technologies Corp.

GridAI Technologies Corp.

GRDX
Rangering i aksjer #31212
GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical... GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.
Aksjekurs
$4.13
Markedsverdi
$13.88M
Endring (1 dag)
4.56%
Endring (1 år)
91.20%
Land
US
Handel GridAI Technologies Corp. (GRDX)

Kategori

EPS for GridAI Technologies Corp. (GRDX)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til GridAI Technologies Corp. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for GridAI Technologies Corp. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -
US
$27.74 -
NL
$2.98 -
AU
- -
CH
$13.70 -
BE